Modalities
Comprehensive End-to-End Solutions
細胞治療
遺伝子治療
治療用抗体
抗体薬物複合体
ワクチン開発
- 研究と開発
- CMC - 製造
- CMC - 品質管理
- 前臨床研究
- 臨床研究
Our Commitment
ACROBiosystems' Core Brand Values
- QUALITY
- INNOVATION
- SERVICE
As we prepare for an international multicentric controlled Phase 3 study evaluating the safety and efficacy of ProtheraCytes in post-acute myocardial infarction patients, we chose ACROBiosystems GMP proteins for their level of documentation, quality control, and regulatory compliance to meet our future commercialization demands.
QUALITY Customer Story
Ibon Garitaonandia, Ph.D., MBA
Chief Scientific Officer, CellProthera
Our Global Reach
Dedicated Local Support, Always on Standby
- Offices
- R&D Centers
- Manufacturing Bases
- Logistics Hubs
London, United Kingdom
Frankfurt, Germany
Paris, France
Basel, Switzerland
Boston, MA, USA
Newark, DE, USA
San Diego, CA, USA
Beijing, China
Seoul, South Korea
Nanjing, China
Suzhou, China
Shanghai, China
Tokyo, Japan
Hangzhou, China
Hong Kong, China
San Jose, CA, USA
Customers
Locations
Employees
- Events
- Activities
North America
ASGCT Annual Meeting 2026
Learn MoreEurope
Innovation for Cell and Gene Therapies Congress 2025
Learn MoreAsia Pacific
